Literature DB >> 9607004

Nitric oxide induction in murine macrophages and spleen cells by whole-cell Bordetella pertussis vaccine.

D K Xing1, C Canthaboo, M J Corbel.   

Abstract

Nitric oxide (NO) induction was studied in the peritoneal macrophages and spleen cells of female NIH mice immunised with whole cell Bordetella pertussis vaccines of moderate and high potency, respectively. Compared with controls receiving diluent only, the macrophages and spleen cells of the vaccinated mice developed high levels of reactive nitrogen intermediates from the third day after injection. The nitrite concentrations achieved maximum values at the 10th day, but significant levels persisted until the 25th day. Heat-killed B. pertussis cells were the most effective inducer of NO synthesis, followed by lipopolysaccharide and agglutinogens Fim 2 and 3. Pertussis toxoid, filamentous haemagglutinin and pertactin were poor inducers of NO synthesis. The specific nitric oxide synthase inhibitor, aminoguanidine, and anti-IFN-gamma antibody blocked formation of nitrite by the macrophages and spleen cells. The production of NO in response to in vitro culture with bacterial antigen was clearly associated with protective immunity in vivo as determined by i.c. challenge. These results suggest that reactive nitrogen intermediates play a role in the immune response induced by whole cell pertussis vaccines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607004     DOI: 10.1016/s0264-410x(97)00157-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Investigation of role of nitric oxide in protection from Bordetella pertussis respiratory challenge.

Authors:  C Canthaboo; D Xing; X Q Wei; M J Corbel
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Effects of iNOS inhibitor on IFN-gamma production and apoptosis of splenocytes in genetically different strains of mice infected with Toxoplasma gondii.

Authors:  Ki-Man Kang; Gye-Sung Lee; Jae-Ho Lee; In-Wook Choi; Dae-Whan Shin; Young-Ha Lee
Journal:  Korean J Parasitol       Date:  2004-12       Impact factor: 1.341

3.  A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response against Bordetella pertussis.

Authors:  Catpagavalli Asokanathan; Michael Corbel; Dorothy Xing
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

4.  Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.

Authors:  Gordon Y C Cheung; Dorothy Xing; Sandra Prior; Michael J Corbel; Roger Parton; John G Coote
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

5.  Evaluation of the Potency of the Pertussis Vaccine in Experimental Infection Model with Bordetella pertussis: Study of the Case of the Pertussis Vaccine Used in the Expanded Vaccination Program in Algeria.

Authors:  Khedidja Tahar Djebbar; Mounia Allouache; Salim Kezzal; Fouzia Benguerguoura; Chafia TouilBoukoffa; Ines Zidi; Rachida Raache; Hadda-Imene Ouzari
Journal:  Vaccines (Basel)       Date:  2022-06-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.